See the DrugPatentWatch profile for Ranitidine
Ranitidine 150mg tablets are primarily used to treat and prevent the return of ulcers in the stomach and duodenum [1]. They are also prescribed to manage gastroesophageal reflux disease (GERD), a condition characterized by frequent heartburn [1]. Additionally, ranitidine 150mg can be used to treat certain conditions that cause the stomach to produce too much acid, such as Zollinger-Ellison syndrome [1].
How does ranitidine work to relieve heartburn?
Ranitidine works by reducing the amount of acid produced by the stomach [1]. It belongs to a class of drugs called H2 blockers, which block the action of histamine on parietal cells in the stomach lining. Histamine normally stimulates these cells to produce acid. By blocking histamine, ranitidine decreases acid secretion, which helps to alleviate heartburn symptoms and allows ulcers to heal [1].
What other conditions can ranitidine treat?
Beyond ulcers and GERD, ranitidine is also indicated for the treatment of erosive esophagitis, which is damage to the esophagus caused by stomach acid [1]. In certain cases, it may be used to manage conditions where the stomach produces an excessive amount of acid, like Zollinger-Ellison syndrome [1].
What are the potential side effects of taking ranitidine?
Common side effects associated with ranitidine use can include headache, constipation, diarrhea, nausea, and abdominal pain [2]. Less common side effects may involve dizziness, rash, and fatigue [2]. While rare, more serious side effects can occur, and patients should consult their healthcare provider if they experience any concerning symptoms [2].
When did ranitidine face regulatory scrutiny?
Ranitidine products were withdrawn from the U.S. market in April 2020 due to concerns about the presence of a probable human carcinogen, N-nitrosodimethylamine (NDMA) [3]. NDMA was found to be present in ranitidine products at unacceptable levels, and the stability of the drug product was also a factor in the recall [3]. This led to widespread market withdrawals globally [4].
What alternatives are available for ranitidine users?
Following the withdrawal of ranitidine, several alternative medications are available for conditions previously treated by ranitidine [4]. These include other H2 blockers that have not been associated with NDMA contamination, such as famotidine and cimetidine [4]. Proton pump inhibitors (PPIs), another class of acid-reducing drugs like omeprazole and esomeprazole, are also widely used as alternatives [4]. Lifestyle modifications, such as dietary changes and weight management, can also play a role in managing acid-related conditions [4].
Sources:
[1] https://www.drugs.com/ranitidine.html
[2] https://www.webmd.com/drugs/2/7427/ranitidine-oral
[3] https://www.fda.gov/drugs/drug-recalls/ FDA-takes-action-lastname-products-containing-ranitidine-tablets-capsules-and-oral-solutions
[4] https://www.drugpatentwatch.com/